中
繁
EN
Search form
Search this site
For Patients
Investors
Careers
Contact
Home
About Us
Our Story
Leadership
Board of Directors
Jacobio people stories
Platform & Pipeline
Platform
Pipeline
Publications
Partnership
News
Company News
Media Report
For patients
9
Clinical Trials Found
All
BRD-NUT
Breast cancer
Prostate cancer
Ovarian cancer
Small bowel cancer
AML
Thyroid cancer
NSCLC
PDAC
CRC
Sarcoma
ACC
Appendiceal cancer
ESCC
PMF
Other advanced solid tumors
Drug:
JAB-21822联合JAB-3312
Indication:
NSCLC
Region:
中国
Link:
JAB-21822联合JAB-3312针对KRAS p. G12C突变的非鳞非小细胞肺癌患者III期确证性研究/JAB-21822-3002
Drug:
JAB-2485单药
Indication:
Other advanced solid tumors
Region:
中国
Link:
Aurora A抑制剂JAB-2485针对晚期实体瘤患者的研究
Drug:
JAB-30355单药
Indication:
Other advanced solid tumors
Region:
中国
Link:
JAB-30355单药治疗携带TP53 Y220C突变的晚期实体瘤的I/IIa期研究
Drug:
JAB-21822单药
Indication:
PDAC
Region:
中国
Link:
JAB-21822针对KRAS p.G12C局部晚期或转移性胰腺癌的II期临床研究
Drug:
JAB-21822联合JAB-3312
Indication:
NSCLC, PDAC, CRC, Other advanced solid tumors
Region:
中国
Link:
JAB-21822联合JAB-3312针对KRAS p. G12C突变晚期实体瘤的I/IIa期研究/JAB-21822-1006
Drug:
JAB-21822联合西妥昔单抗
Indication:
Small bowel cancer, CRC, Appendiceal cancer
Region:
中国
Link:
JAB-21822联合EGFR单抗针对KRAS p.G12C 突变的晚期结直肠癌、晚期小肠癌、晚期阑尾癌的Ib/II期临床研究/JAB-21822-1007
Drug:
JAB-8263单药
Indication:
AML, PMF
Region:
中国
Link:
JAB-8263在晚期恶性肿瘤患者的I/IIa期临床研究/JAB-8263-1002
Drug:
JAB-8263单药
Indication:
BRD-NUT, Breast cancer, Prostate cancer, Ovarian cancer, Other advanced solid tumors
Region:
中国, 美国
Link:
JAB-8263在晚期恶性肿瘤患者的I/IIa期临床研究/JAB-8263-1002
Drug:
JAB-BX102单药
Indication:
Thyroid cancer, Sarcoma, ACC, Other advanced solid tumors
Region:
中国, 美国
Link:
JAB-BX102用于晚期恶性肿瘤的I/IIa期临床研究/JAB-BX102-1001